CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $138.49M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 4.42: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
196.19BKRW138.49M · vs all stocks (USD)
Revenue (TTM)
19.95BKRW14.09M · vs all stocks (USD)
Profit Margin
-54.43%Beta
0.5880xvs all stocks
52-Week Change
-51.43%vs all stocks
Market Capitalization
196.19BKRW138.49M · vs all stocks (USD)
Enterprise Value
184.87BKRW130.50M · vs all stocks (USD)
Price to Sales (TTM)
10.21xPrice to Book (MRQ)
3.64xEnterprise to Revenue
9.27xEnterprise to EBITDA
-58.19xGross Margin
25.37%Profit Margin
-54.43%Operating Margin
-34.79%Return on Assets (TTM)
-7.05%Return on Equity (TTM)
-18.92%Revenue (TTM)
19.95BKRW14.09M · vs all stocks (USD)
Revenue per Share (TTM)
900.78KRWUpdated Jul 15, 2026Quarterly Revenue Growth
25.30%Gross Profit (TTM)
5.05BKRW3.56M · vs all stocks (USD)
EBITDA (TTM)
-3.18BKRW-2.24M · vs all stocks (USD)
Net Income (TTM)
-10.86BKRW-7.67M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
25.29%Operating Cash Flow (TTM)
-2.39BKRW-1.69M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-10.07BKRW-7.11M · vs all stocks (USD)
Payout Ratio
0.00%Minority Interest (Equity)
180.75MKRWFY2025 · Dec 31, 2025Revenue
18.67BKRWFY2025 · Dec 31, 2025Cost of Goods Sold
14.37BKRWFY2025 · Dec 31, 2025Gross Profit
4.30BKRWFY2025 · Dec 31, 2025Operating Income
-7.75BKRW-5.47M · vs all stocks (USD)
Pre-tax Income
-11.09BKRWFY2025 · Dec 31, 2025Income Tax Expense
121.12MKRWFY2025 · Dec 31, 2025Net Income
-11.21BKRWFY2025 · Dec 31, 2025EBIT
-10.04BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
-2.23BKRWFY2025 · Dec 31, 2025Research & Development
3.58BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
1.97BKRWFY2025 · Dec 31, 2025Other Operating Expenses
-2.95MKRWFY2025 · Dec 31, 2025Non-operating Interest Income
881.92MKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
1.04BKRWFY2025 · Dec 31, 2025Net Income from Continuing Operations
-11.21BKRWFY2025 · Dec 31, 2025Minority Interests (P&L)
-43.44MKRWFY2025 · Dec 31, 2025Operating Cash Flow
-12.87BKRWFY2025 · Dec 31, 2025Free Cash Flow
-19.22BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.34BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-11.21BKRWFY2025 · Dec 31, 2025Stock-based Compensation
34.55MKRWFY2025 · Dec 31, 2025Other Non-cash Items
775.82MKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-2.23BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-243.77MKRWFY2025 · Dec 31, 2025Capital Expenditures
-6.35BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.18BKRWFY2025 · Dec 31, 2025Purchase of Investments
-71.28BKRWFY2025 · Dec 31, 2025Sale of Investments
78.40BKRWFY2025 · Dec 31, 2025Other Investing Activity
523.88MKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
1.29BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-54.13KKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
2.77BKRWFY2025 · Dec 31, 2025Other Financing Charges
-10.00KRWFY2025 · Dec 31, 2025Net Financing Cash Flow
2.77BKRWFY2025 · Dec 31, 2025Shares Outstanding
22.42MSharesUpdated Jul 15, 2026Float Shares
19.17MSharesUpdated Jul 15, 2026% Held by Insiders
13.30%vs all stocks
% Held by Institutions
2.55%vs all stocks
Total Cash (MRQ)
23.92BKRW16.89M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.08KKRWUpdated Jul 15, 2026Total Debt (MRQ)
5.53BKRW3.90M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1011xCurrent Ratio (MRQ)
3.01xBook Value per Share (MRQ)
2.39KKRWUpdated Jul 15, 2026Total Assets
74.53BKRW52.61M · vs all stocks (USD)
Total Current Assets
34.56BKRWFY2025 · Dec 31, 2025Total Liabilities
19.70BKRWFY2025 · Dec 31, 2025Total Non-current Assets
39.97BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
5.10BKRWFY2025 · Dec 31, 2025Total Current Liabilities
14.60BKRWFY2025 · Dec 31, 2025Cash Equivalents
4.34BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.34BKRWFY2025 · Dec 31, 2025Other Short-term Investments
22.20BKRWFY2025 · Dec 31, 2025Accounts Receivable
5.33BKRWFY2025 · Dec 31, 2025Inventory
1.56BKRWFY2025 · Dec 31, 2025Accounts Payable
1.72BKRWFY2025 · Dec 31, 2025Short-term Debt
4.81BKRWFY2025 · Dec 31, 2025Other Current Liabilities
2.49KKRWFY2025 · Dec 31, 2025Long-term Debt
2.68BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
-40.00KRWFY2025 · Dec 31, 2025Common Stock (Book)
11.21BKRWFY2025 · Dec 31, 2025Retained Earnings
-89.69BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
54.83BKRW38.71M · vs all stocks (USD)
Treasury Stock
48.47MKRWFY2025 · Dec 31, 202552-Week Low
8.48KKRWUpdated Jul 15, 202652-Week High
35.05KKRWUpdated Jul 15, 202652-Week Change
-51.43%vs all stocks
Beta
0.5880xvs all stocks
50-Day MA
13.40KKRWUpdated Jul 15, 2026200-Day MA
21.01KKRWUpdated Jul 15, 2026Avg 10-Day Volume
61.49KSharesUpdated Jul 15, 2026Avg 30-Day Volume
107.29KSharesUpdated Jul 15, 2026Diluted EPS (TTM)
-508.00KRWUpdated Jul 15, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Decline With Range Expansion And Drawdown
The price is falling, swinging wider than usual, and sits well below its peak.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.42: safe zoneNotable
Altman Z-Score: 4.42
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $138.49M, lower than 95% of all stocks globallySignificant
Market cap (USD): 138,493,477.839Global P5: 269,387,740.27
Revenue is $14.09M, lower than 95% of all stocks globallySignificant
Revenue (USD): 14,085,904.387Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
Scancell Holdings Plc
Tier 1ProductionApproval-Gated PipelineRuleRisk
Curacle Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Pyridam Farma Tbk.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Enlivex Therapeutics Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
CVRx, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Yungjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
HLB Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
3Billion Inc.
Tier 1ProductionApproval-Gated PipelineSenseMakingRule
EKF Diagnostics Holdings plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
S Biomedics Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationDecline With Range Expansion And Drawdown
Neuromeka Co., Ltd.
1 interpretationDecline With Range Expansion And Drawdown
Shanghai Geoharbour Construction Group Co. Ltd.
1 interpretationDecline With Range Expansion And Drawdown